Squarepoint’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Squarepoint’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,007	Closed	-$500K	–	5628
2024 Q3	$500K	Buy	15,007 +1,035	+7%	+$35.6K	﹤0.01%	3094
2024 Q2	$378K	Buy	13,972 +3,260	+30%	+$64.3K	﹤0.01%	3280
2024 Q1	$231K	Buy	+10,712	New	+$234K	﹤0.01%	3537

Squarepoint's LBPH Position: Q4 2024 in Review

Squarepoint sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 15,007 shares — an estimated $500K sold.

Squarepoint first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $500K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Squarepoint reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Squarepoint sold 15,007 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $500K.
Squarepoint first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Squarepoint's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $500K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.